VS management can be surgical, by radiosurgery or watchful waiting. Middle fossa approach (MCF) can be implemented in small and some medium-size tumours, and has the potential to preserve hearing. The authors measured quality of life of VS patients who...
A total laryngectomy remains the gold standard for the initial treatment of advanced (T4) squamous cell carcinomas of the larynx without evidence of distant disease. Adjuvant radiotherapy (RT) is also recommended for such cancers. In the absence of other adverse...
An estimated 750 million people worldwide were affected by Covid-19. A significant proportion have been left with long-term symptoms for which the World Health Organization has proposed the term ‘post-Covid condition’ (PCC). Dizziness is but one of the symptoms. Dizziness...
The link between obstructive sleep apnoea (OSA) and cardiovascular disease (CVD) is clear. Its well-established association with essential hypertension is thought to link OSA to an increased risk of atherosclerotic and hypertensive sequelae. However, data on the long-term impact of...
Vocal tremor (VT) is a debilitating problem, but remains challenging to treat. Its pathophysiology remains indeterminate and there is a lack of consensus on phenotypes. Clinically, VT is often noted to be present in muscles outside of the larynx, including...
Recurrent squamous cell carcinoma of the head and neck is often a challenge to manage when radiotherapy has previously been administered as a component of the initial treatment. Salvage surgery is usually the preferred modality of treatment, but for unresectable...
Transoral laser microsurgery (TOLM) remains the cornerstone of treatment for early laryngeal squamous cell carcinomas. Whilst the hope is always to achieve a complete surgical excision with clear margins, it is sometimes the case that on histological analysis, disease is...
AI is certainly a topical issue these days and radiomics refers to techniques which allow the extraction of quantitative features from medical imaging to produce large data sets for clinical problem solving. This paper looks at CT imaging of the...
This systematic review investigates the comparative cognitive outcomes in children using bilateral versus unilateral cochlear implants, as well as those using cochlear implants versus hearing aids. The review synthesises findings from 30 studies involving a total of 11,986 children and...
Dupilumab is a humanised monoclonal antibody that targets type 2 inflammation by blocking IL-4 and IL-13 signalling. Reported adverse events from its use include injection site erythema, conjunctivitis, arthralgia and hypereosinophilia. The potential for more severe eosinophilic-related complications such as...
HIMSA announces its first-ever participation at the British Academy of Audiology (BAA) Annual Conference and Exhibition, November 21-22 2024, in Telford. And we are really looking forward to it! “UK hearing care professionals have long been among the most active...
Rob Atkinson, Chief Executive of DP Medical Systems, said: “It is with great sadness that we announce the recent death of our company founder and namesake, Douglas Pitman, on Saturday 6 September 2025, after a long illness. The late Douglas...